ArticleHuman vaccines & immunotherapeutics2021

Potential public health impact of the adjuvanted recombinant zoster vaccine among people aged 50 years and older in Beijing.

Christa Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.